Chlorosartan-induced hypotension leads to tau protein hyperphosphorylation and memory impairment, possibly via oxidative stress-induced tau protein hyperphosphorylation and dendritic spine loss, increasing the risk of AD-like pathological changes and behavioural disorders. The gene discussed is MAPT; the disease is Alzheimer disease.